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Introduction
Mesenchymal stem cells (MSCs) were originally isolated from the 
yellow bone marrow located in the medullary cavity of  long bones 
of  mouse by Friedenstein et al. [1]. Consequent studies confirmed 
that these cells could also be isolated from the human bone mar-
row and have the potential to differentiate into cells with mes-
enchymal lineages such as adipocytes, chondrocytes, myoblasts 
and osteoblasts [2]. These cells are capable of  proliferation, 
self-renewal and regeneration into tissues of  mesenchymal line-
age. MSCs from bone marrow have been isolated from different 
species including mouse, rat, rabbit, monkey and human [3-7]. 
Although the cells share several characteristics, variations occur 
among the species in the expression of  antigens [8]. Among the 
various methods of  the isolation of  MSCs (plastic adherence, 
density gradient centrifugation and immunomagnetic selection), 
plastic adherence is an easy and popular method [9-11]. Plastic ad-
herence failed to yield relatively homogeneous MSCs population 
from the murine bone marrow because of  the hematopoietic cell 
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Background: The differentiation potential of  mesenchymal stem cells (MSCs) derived from the bone-tissue to multiple 
lineages is not clear. 
Objective: This study was conducted to investigate the surface antigen expression and multilineage stem cell potential of  
the cells derived from culture of  collagenase digested marrow-free compact bones of  C57BL/6 mouse. 
Materials & Methods: Long bones of  C57BL/6 mouse (n=6) were collected aseptically and bone marrow was flushed 
out. Collagenase-digested bone fragments were washed and cultured in plastic flasks. The plastic-adherent fibroblast-like 
spindle-shaped cells were cultured sequentially in multiple passages in low-glucose DMEM (Dulbecco’s Modified Eagle’s 
Medium) supplemented with 15% FBS (Foetal Bovine Serum) and antibiotics in a 37°C incubator with 5% CO2. Immu-
nophenotyping for cell surface markers was done using flow cytometry. The cells were differentiated into the osteoblastic, 
adipogenic and chondrogenic lineages.
Results: The culture of  the adherent cells exhibited active proliferation and multiplication in consequent passages. The 
cultured cells revealed evidence of  adipogenic and osteogenic differentiation confirmed by staining with oil red O and von 
Kossa stains. Under flow cytometry observation, a significant proportion of  cultured cells expressed CD29 and stem cell 
antigen (Sca-1). Only 9.8% cells showed expression of  CD105. These MSCs exhibited low ability in chondrogenic dif-
ferentiation, which can potentially be attributed to their lack of  CD105 expression. Lack of  expression of  CD45 showed 
evidence of  absence of  hematopoietic stem cells. 
Conclusion: This study showed that murine compact bone-chip culture can yield MSCs with significant proliferation ca-
pacity. The cells displayed the ability to differentiate into osteoblast and adipocyte lineages. 
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contamination [12]. Separation of  the hematopoietic stem cells 
from the bone marrow-derived MSCs requires multiple passaging 
of  the culture.
Isolation and culture of  mouse MSCs from the compact bone 
was proposed to be easier compared to the similar culture from 
the bone marrow [13, 14].  Explant culture from the trabecular 
bone pieces showed the presence of  MSCs that could differenti-
ate into osteoblasts, adipocytes and chondrocytes. These cells also 
expressed surface antigens similar to the bone marrow-derived 
MSCs, such as lacking the hematopoietic and common leukocyte 
markers (CD45), and  expressing the markers related to adhesion 
(CD29) and stem cells (CD105) [15]. However it was reported 
that compared to the bone marrow-derived MSCs, compact 
bone-derived MSCs showed reduced capacity for multi-lineage 
differentiation [15].  In this study, we isolated, expanded and char-
acterized MSCs by the primary culture of  compact bone chips 
from C57BL/6 mouse using standard method of  plastic adher-
ence to test the differentiation potential and expression of  surface 
antigens.
Materials and Methods
Mice
Four-week-old female C57BL/6 mice (n=6) were maintained at 
the animal facility of  the university. All mice were housed under 
specific pathogen-free conditions. The procedures on the mice 
were approved by the Animal Care and Use Committee of  the 
university.
Isolation of  plastic adherent MSCs from culture of  compact 
bone
The C57BL/6 mice were sacrificed under anesthesia followed by 
cervical dislocation. Femur, tibia and humerus bones were cut in 
between the upper and lower epiphyses and collected under asep-
tic condition. The bones were separated from the muscles and 
soft tissues by gentle abrasion using sterile gauze pieces. Bone 
marrow was flushed out by injecting Hank’s balanced salt solution 
into the medullary cavity, until the bone pieces became pale. The 
marrow-free bones were then chopped into minute pieces using 
the micro-dissecting scissors. Dulbecco’s Modified Eagle Medi-
um (DMEM) which contained 1000 mg/L glucose, 584 mg/L 
L-Glutamine and, was supplemented with 15% MSC qualified 
Fetal Bovine Serum (FBS), 100 IU/mL Penicillin and 100 μg/mL 
Streptomycin (all from GIBCO), was used to store the bones and 
for subsequent cultures. The bone pieces were digested in a mix-
ture of  DMEM and Collagenase II (GIBCO) (1 mg ml–1 weight/
volume) for 2 hours in a shaking incubator (37°C, 200 rpm). This 
resulted in the formation of  a coagulum because of  the adher-
ence of  the bony pieces with each other. The medium was aspirat-
ed and discarded. The bone chips were washed three times with 
the DMEM. The bone chips were then plated in a 25 cm2 plastic 
culture flask in low glucose DMEM supplemented with FBS and 
antibiotics, in proportion, as described above, and incubated at 37 
°C in 5% CO2.  On the third day, the non-adherent circular float-
ing cells were removed by a complete media change. After seven 
days, the adherent MSCs were harvested by trypsinization with 
0.25% trypsin containing 1 mM EDTA (GIBCO). The cell count 
was done using the Trypan blue exclusion assay and plating was 
done at variable densities ranging from 1600 to 2500 cells/cm2. 
The adherent cells were cultured in consecutive passages once per 
week at a split ratio of  1:2 until the 12th passage. The variation in 
the cell count in consecutive passages was monitored.
Differentiation of  plastic adherent MSCs
Differentiation to adipocyte: The MSCs obtained based on 
plastic adherence from bone chips culture in passage-4 were plat-
ed at a density of  1 X 104 cells in Mesencult proliferation media 
(Stemcell Technologies, Canada) in each well of  a 6-well plate. 
The culture was maintained for seven days or until the adherent 
layer of  at least 80% confluence was formed. The media was aspi-
rated and replaced with Mesencult basal medium containing 20% 
Mesencult adipogenic stimulatory supplement (Stemcell Tech-
nologies, Canada). The medium was replenished once every three 
days for three weeks. The adipogenic stimulatory supplement 
contained dexamethasone, indomethacin and insulin. Adipocytes 
differentiated from MSCs were  fixed with 4% paraformaldehyde, 
washed with 60% isopropanol and then stained with oil red O fol-
lowed by counterstaining of  nuclei by haematoxylin.
Differentiation to osteoblast: Passage-4 MSCs were plated in 
proliferation media in a 6-well plate as described above in adipo-
cyte differentiation. When the cultured cells were 80% confluent, 
the proliferation media was replaced with Mesencult basal me-
dium containing 25% Mesencult osteogenic stimulatory supple-
ment (Stemcell Technologies, Canada). The osteogenic stimula-
tory supplement contained dexamethasone, β-glycerophosphate 
and ascorbic acid. The medium was replenished once every three 
days for three weeks. The brownish-black deposits at the bottom 
of  the plate indicated appearance of  calcium salts, which were 
further identified using von Kossa staining. The differentiated 
cells were fixed with 4% paraformaldehyde, incubated with 1% 
silver nitrate for 2 hours followed by removal of  un-reacted silver 
with 5% sodium thiosulphate.
Differentiation to chondrocyte: Passage-4 MSCs were subcul-
tured consecutively in low-glucose DMEM with 15% FBS till pas-
sage-7 cells with 90% confluence were seen. The adherent cells 
were trypsinized and cell viability was assessed. With 1 x 105 viable 
cells per cm2 and single cell suspension, a micromass culture was 
generated by seeding 5-microliter droplets of  cell solution (con-
taining 8x104 cells) in the center of  a well within a 6-well plate. 
The micromass culture was cultivated for 2 hours under high-
humidified condition in a 370C incubator with 5% CO2. StemPro 
chondrogenesis differentiation media (GIBCO) was added. The 
media was serum-free and low-glucose. The media was supple-
mented every third day until the 21st day. After that, chondro-
genic pellet was stained using 1% Alcian blue solution.
Immuophenotyping
MSCs were analyzed for cell surface marker expression at pas-
sage-4 and passage-7. The cells were trypsinized, washed with 
staining buffer and incubated (1 X105 cells in 100 µL) with com-
bination of  antibodies (10 µL each) for 45 minutes in the dark 
at 40C. The antibodies used were CFS-anti-rat-CD105, PE-anti-
rat-CD29, APC-anti-rat-Sca-1 and PerCP-anti-rat-CD45. All an-
tibodies were purchased from R&D Systems, USA. Analysis was 
done in BD Acuuri C6 flow cytometer using CFlow Plus software. 
Isotype-matched antibodies were used as controls to determine 
non-specific staining.
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Results and Discussion
Cell Cultures
The cultures were observed daily by using a phase contrast in-
verted microscope to examine the morphology of  the adherent 
cells. Primary culture from the bone chips showed some cells with 
circular shape and some with spindle shape with two processes on 
each side (Figure. 1a).  During passage-1 and 2, in about four days’ 
time after trypsinization and establishment of  next passage of  
culture, individual adherent cells occupied about 90% of  the sur-
face of  the culture flask (Figure. 1b). Remaining cells in the flask 
were floating and circular in shape. The adherent cells looked like 
fibroblasts with elongated cell bodies and long processes. From 
passage-3 onwards, the size of  the adherent cells increased and 
the cell body appeared either triangular or polyhedral with long 
processes and central nucleus. The amount of  floating cells was 
also reduced. We propose that the adherent cells were MSCs be-
cause they exhibited the capacity to proliferate extensively in sub-
sequent cultures until passage-12 and differentiate into adipocyte, 
osteoblast and chondrocyte.
Proliferation of  the Adherent Cell Population
The adherent cells showed active proliferation in subsequent sub-
cultures and the number of  viable cells observed with the Trypan 
blue exclusion assay in passage-5 was double to the number of  
cells plated in first primary culture (passage 0) with plating density 
of  2000 cells/cm2 (Figure. 2). The proliferation of  the cells was 
comparatively more in passage-5 with primary plating density of  
500 cells/cm2 (nearly 5-times as shown in sample M3, Figure 2). 
The rate of  proliferation slowed down when the cultivated cells 
reached passage-7, but it was possible to cultivate the cells until 
passage -12 (Figure1, Figure2).
Differentiation to adipocyte
The treatment of  the MSCs in passage-4 with the adipogenic 
stimulatory supplement resulted in the differentiation of  MSCs 
into adipocytes. Small lipid droplets appeared within the cyto-
plasm of  a few differentiated cells, on the day 7 after addition of  
the adipogenic stimulatory supplement and occupied the whole 
cytoplasm of  most of  the cells, after 4 weeks. Lipid droplets with-
in the cytoplasm of  the differentiated cells were observed under 
oil red O staining (Figure. 3A 2) and compared with the control 
(Figure.3A 1).
Differentiation to osteoblast
Passage-4 MSCs when cultured in the osteogenic stimulatory sup-
plement, differentiated into the osteoblast cells which started ac-
cumulating calcium in the extracellular matrix. The deposits were 
perceptible on the seventh day of  culture. At 4th week, the larger 
areas of  calcification nodules turned dark-brown, with von Kossa 
staining (Figure. 3B 2).
Differentiation to chondrocyte
To induce chondrogenic differentiation, adherent cells of  pas-
sage-7 were cultured under hypoxic and serum-free conditions in 
pellet form. After 21 days, when the pellet was stained with Alcian 
blue, blue stained areas in between the cells indicated synthesis 
of  proteoglycans (Figure. 3C 2).  However the blue-stained areas 
were observed only towards the edge of  the pellet indicating re-
duced chondrogenic differentiation of  the MSCs cultivated in this 
study.  Previous study has observed that the selection of  CD105 
positive MSCs favors chondrogenesis [16]. CD105 is an acces-
sory protein of  TGF-β super family kinase receptor complexes. 
TGF-β3 is the key transcription factor for differentiating MSCs 
into chondrocytes [17]. In this study, only a small proportion of  
the cultured MSCs expressed CD105, suggesting that this could 
be a potential reason for the reduced chondrogenic differentiation 
observed in this study (Figure 4) (Figure3).
Phenotypic characterization
Flow cytometry analysis revealed that more than 98% of  the 
MSCs expressed Sca-1 and more than 63% of  the MSCs ex-
pressed CD29 (Figure 4). Both Sca-1 and CD29 have been re-
ported as surface-markers for mouse MSCs. Absence of  CD45 
positive cells (0.6%) indicated that the culture was devoid of  the 
cells of  hematopoietic origin. A small percentage (9.8%) of  the 
cultured cells was positive for CD105. The origin of  the cultured 
cells was from the marrow-free compact bone chips. Previous 
studies have linked the absence of  CD105 expression with iden-
tification of  MSCs having increased osteogenic gene expression 
[18, 19].  Lower percentage of  cultured MSCs expressing CD105 
phenotype observed in this study can be extrapolated to the ori-
Figure 1. Morphological features of  cultured cells from collagenase digested murine compact bone chips. (a) At 48 hours 
after initial culture, both fibroblast-like cells and round cells sprouted out from the bone fragments. (b) At 4th day after 
subculture, adherent cells with fibroblast-like morphology occupied 90% of  the surface of  the flask.
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Figure 2. Bar chart showing the count of  viable cells observed under Trypan blue exclusion assay during subsequent 
subculture from passage-0 (P0) to passage-5 (P5). The compact bone culture sample established from individual mouse is 
labelled as M1, M2, M3 and M4.
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Figure 3. Phase contrast photomicroscopy of  multilineage differentiation of  the mesenchymal stem cells derived from mu-
rine compact bone chips culture. (3A 1) control undifferentiated MSC culture and (3A 2) Fat droplets in the differentiated 
adipocytes stained red (20x, Oil Red O stain). (3B 1) control undifferentiated MSC culture and (3B 2) dark-brown calcium 
salt deposits in the extracellular matrix of  differentiated osteoblast cells (20X, von Kossa stain). (3C 1) peripheral part of  
pellet of  control undifferentiated MSC culture and (3C 2) bluish stained proteoglycans (red arrow) in between differentiated 
chondrocytes (10X, Alcian blue stain); Bar 50 µm.
Figure 4. Flow cytometry analysis for phenotypic characterization of  compact bone derived murine MSCs. The histogram 
with red lines shows isotype controls and histogram with gray line shows reactivity with indicated antibodies. Majority of  
cells were positive for Sca-1(98.2%) and CD29 (63.4%). Only a small subpopulation of  cells (9.8%) was positive for CD105. 
Cultured MSCs showed lack of  CD45 expression.
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gin of  the cultivated cells from the marrow-free compact bone 
(Figure4).
Compact bone-derived mouse MSC and CD105 phenotype
Compact-bone culture can yield good source of  the mouse MSCs 
with relatively less capacity in multi-lineage differentiation after 
passage-10. Zhu et al., (2010) proposed a protocol that could yield 
a homogeneous population of  mouse MSCs within a short pe-
riod of  time [20]. Present study followed the protocol proposed 
by Zhu et al. However compared to Zhu et al. study, which had 
reported 95% of  the MSCs expressing CD105, this study, ob-
served only 9.8% expression of  CD105. The use of  low-glucose 
DMEM and lack of  specific amino acids like ribonucleosides and 
ribonucleotides might have prevented expression of  CD 105.  In 
a similar study of  compact-bone derived mouse MSCs, Guo et al., 
(2006) observed that the proportion of  CD105 cells decreased 
progressively in subsequent subcultures [21]. In a previous study, 
CD105-negative subpopulations of  MSCs derived from the syno-
vial membrane failed to form prominent pellet in chondrogenic 
differentiation media [22]. Anderson et al., (2013) proposed to 
redefine CD105 expression of  mouse MSC and showed that 
CD105-negative cells suppressed the proliferation of  CD4+ 
T cells more efficiently compared to CD105 positive cells [23]. 
MSCs cultured from the compact bone showed lack of  CD105 
expression in this study. Compact-bone derived MSCs can be 
attributed with promising experimental study value due to their 
unique surface antigen expression and lack of  contamination with 
haematopoietic cells. This characterization was essential for the 
second part of  our study in which we are planning to use these 
cells in vivo to restrore locomotion in mouse model of  experi-
mental autoimmune encephalomyelitis.
Conclusion
In this study, culture of  the collagenase-digested compact bones 
from young 4-week-old C57BL/6 mouse showed presence 
of  MSCs with significant proliferation capacity. The cells were 
characterized by prominent expression of  surface markers, Sca-
1 and CD29, and relatively little expression of  CD105, in flow 
cytometry. Lack of  CD45 surface marker indicated absence of  
hematopoietic cells. These cultured cells displayed the ability to 
differentiate into osteoblast and adipocyte lineages when stimu-
lated in the appropriate differentiating conditions. However, lack 
of  prominent chondrocytic differentiation of  the cultured cells, 
was extrapolated to be due to the relatively little populations of  
cells expressing CD105.
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